Aurobindo Pharma Limited Cash Flow Reinvestment Rate
Aurobindo Pharma Limited cash flow reinvestment rate. Aurobindo Pharma Limited (AUROPHARMA) has a Cash Flow Reinvestment Rate of 0.47x as of September 2025, reinvesting Rs13.63 Billion (capex Rs13.63 Billion ) from operating cash flow of Rs28.85 Billion. See Aurobindo Pharma Limited (AUROPHARMA) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Aurobindo Pharma Limited (2004–2026)
Cash flow reinvestment rate of Aurobindo Pharma Limited from 2004 to 2026. Historical reinvestment intensity for Aurobindo Pharma Limited across 22 annual periods. Explore AUROPHARMA operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Aurobindo Pharma Limited Cash Flow Reinvestment Rate by Year (2004–2026)
Aurobindo Pharma Limited cash flow reinvestment rate by year from 2004 to 2026. Year-by-year capital reinvestment analysis for Aurobindo Pharma Limited. For the full cash flow conversion analysis, see AUROPHARMA cash generation efficiency.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.68x | Rs37.68 Billion | Rs55.13 Billion | Rs26.86 Billion | ▼ -30.2% |
| 2025 | 0.98x | Rs38.44 Billion | Rs39.25 Billion | Rs19.68 Billion | ▼ -69.5% |
| 2024 | 3.21x | Rs78.17 Billion | Rs24.35 Billion | Rs35.62 Billion | ▲ +14.4% |
| 2023 | 2.81x | Rs66.98 Billion | Rs23.87 Billion | Rs27.20 Billion | ▲ +351.9% |
| 2022 | 0.62x | Rs31.16 Billion | Rs50.16 Billion | Rs27.05 Billion | ▼ -12.7% |
| 2021 | 0.71x | Rs23.68 Billion | Rs33.29 Billion | Rs18.74 Billion | ▲ +92.6% |
| 2020 | 0.37x | Rs16.19 Billion | Rs43.81 Billion | Rs14.31 Billion | ▼ -62.6% |
| 2019 | 0.99x | Rs16.31 Billion | Rs16.51 Billion | Rs15.59 Billion | ▲ +20.9% |
| 2018 | 0.82x | Rs15.98 Billion | Rs19.55 Billion | Rs15.30 Billion | ▲ +47.9% |
| 2017 | 0.55x | Rs18.12 Billion | Rs32.79 Billion | Rs16.94 Billion | ▼ -50.9% |
| 2016 | 1.12x | Rs15.97 Billion | Rs14.20 Billion | Rs15.66 Billion | ▲ +76.6% |
| 2015 | 0.64x | Rs7.88 Billion | Rs12.37 Billion | Rs7.68 Billion | ▼ -49.5% |
| 2014 | 1.26x | Rs8.15 Billion | Rs6.46 Billion | Rs3.90 Billion | ▲ +26.8% |
| 2013 | 0.99x | Rs2.73 Billion | Rs2.75 Billion | Rs2.73 Billion | ▼ -43.2% |
| 2012 | 1.75x | Rs5.71 Billion | Rs3.26 Billion | Rs5.71 Billion | ▼ -18.0% |
| 2011 | 2.14x | Rs7.16 Billion | Rs3.35 Billion | Rs7.16 Billion | ▲ +118.1% |
| 2010 | 0.98x | Rs4.20 Billion | Rs4.29 Billion | Rs4.20 Billion | ▼ -72.4% |
| 2009 | 3.55x | Rs4.83 Billion | Rs1.36 Billion | Rs4.83 Billion | ▲ +128.8% |
| 2008 | 1.55x | Rs2.46 Billion | Rs1.59 Billion | Rs2.46 Billion | ▼ -91.3% |
| 2007 | 17.79x | Rs3.32 Billion | Rs186.50 Million | Rs3.32 Billion | ▲ +560.9% |
| 2005 | 2.69x | Rs3.29 Billion | Rs1.22 Billion | Rs3.29 Billion | ▼ -73.3% |
| 2004 | 10.08x | Rs2.00 Billion | Rs198.90 Million | Rs2.00 Billion | — |